In glioblastoma models, the combined inhibition of FGFR and reduced CLK2 expression synergistically induced apoptosis and cell cycle arrest, suggesting that pathways regulated by CLK2 may mediate resistance to single-agent FGFR inhibition (Park et al., 2020). The gene discussed is CLK2; the disease is glioblastoma.